New injection aims to stop Cancer's return after liver treatment
Disease control
Not yet recruiting
This study is testing if a new injectable drug, called IP-001, can help prevent cancer from returning after a standard heat-based treatment (ablation) for colorectal cancer that has spread only to the liver. Researchers want to see if injecting IP-001 into the treated tumor area …
Phase: PHASE2, PHASE3 • Sponsor: Immunophotonics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC